Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis

Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage

(2018) Shahzma Merani et al.   EXPERIMENTAL GERONTOLOGY

Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis

(2018) Jason K. H. Lee et al.   Expert Review of Vaccines

Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness

(2018) Melissa A. Rolfes et al.   Influenza and Other Respiratory Viruses

Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients

(2018) Yinong Young-Xu et al.   JOURNAL OF INFECTIOUS DISEASES

Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis

(2018) Jessica J. Bartoszko et al.   VACCINE

Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012–2013 and 2013–2014

(2017) David K. Shay et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis

(2017) Krista Wilkinson et al.   VACCINE

Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion

(2017) Mark A. Pilkinton et al.   VACCINE

Feasibility of a cluster-randomized influenza vaccination trial in U.S. nursing homes: Lessons learned

(2017) Stefan Gravenstein et al.   Human Vaccines & Immunotherapeutics

Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial

(2017) Stefan Gravenstein et al.   Lancet Respiratory Medicine

Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients

(2016) Natasha B. Halasa et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial

(2016) Andrew J. Dunning et al.   Clinical and Vaccine Immunology

Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults

(2016) Carlos A. DiazGranados et al.   CLINICAL INFECTIOUS DISEASES

Fluzone® High-Dose Influenza Vaccine

(2016) Corwin A. Robertson et al.   Expert Review of Vaccines

High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses

(2016) Jin Hyang Kim et al.   VACCINE

Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial

(2016) Saad Jamshed et al.   VACCINE

Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection

(2016) Hana Hakim et al.   VACCINE

Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis

(2015) Hector S Izurieta et al.   LANCET INFECTIOUS DISEASES

Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50–64 years of age

(2015) Carlos A. DiazGranados et al.   VACCINE

Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty

(2015) Carlos A. DiazGranados et al.   VACCINE

Influenza vaccination in immunocompromised patients: efficacy and safety

(2014) Delphine Zbinden et al.   Immunotherapy

Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status

(2014) Gonçalo Matias et al.   Influenza and Other Respiratory Viruses

Randomized, Controlled Trial of High-Dose Influenza Vaccine Among Frail Residents of Long-Term Care Facilities

(2014) David A. Nace et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

(2014) Carlos A. DiazGranados et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients

(2014) Sarah GiaQuinta et al.   PEDIATRIC TRANSPLANTATION

T cell mediated immunity to influenza: mechanisms of viral control

(2014) Nicole L. La Gruta et al.   TRENDS IN IMMUNOLOGY

Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects

(2014) Sharon E. Frey et al.   VACCINE

Age- and Sex-related Risk Factors for Influenza-associated Mortality in the United States Between 1997–2007

(2013) Talia M. Quandelacy et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Improved Immunogenicity With High-Dose Seasonal Influenza Vaccine in HIV-Infected Persons

(2013) Noah McKittrick   ANNALS OF INTERNAL MEDICINE

Immunological assessment of influenza vaccines and immune correlates of protection

(2013) Adrian Reber et al.   Expert Review of Vaccines

Preventing or reversing immunosenescence: can exercise be an immunotherapy?

(2013) Adriana L de Araújo et al.   Immunotherapy

Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase

(2013) Robert B. Couch et al.   JOURNAL OF INFECTIOUS DISEASES

Cellular immune correlates of protection against symptomatic pandemic influenza

(2013) Saranya Sridhar et al.   NATURE MEDICINE

Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia

(2013) Meghann McManus et al.   PEDIATRIC BLOOD & CANCER

Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial

(2013) Peter Tsang et al.   VACCINE

High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009–2010 season

(2012) Carlos A. DiazGranados et al.   VACCINE

Improving immunogenicity and effectiveness of influenza vaccine in older adults

(2011) Weiping Cao et al.   Expert Review of Vaccines

Immunogenicity and safety of inactivated influenza vaccines in primed populations: A systematic literature review and meta-analysis

(2011) W.E.P. Beyer et al.   VACCINE

Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine

(2011) Wilbur H. Chen et al.   VACCINE

Influenza vaccine responses in older adults

(2010) Janet E. McElhaney   AGEING RESEARCH REVIEWS

Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older

(2009) Ann R. Falsey et al.   JOURNAL OF INFECTIOUS DISEASES

Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults

(2009) Janet E. McElhaney et al.   VACCINE

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

(2009) Thomas R. Cate et al.   VACCINE